Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cells
OwnerZhenglun Zhuinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to human homeobox transcription factor VentX and its regulation of differentiation and maturation of human dendritic cells, and related therapeutic and diagnostic compositions and methods of use.
Claims19
A method for regulating dendritic cells, comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising a biological or chemical agent that exerts a modulating effect of human homeobox gene VentX.
6-7. (canceled)
9-12. (canceled)
A pharmaceutical composition comprising a biological or chemical agent that exerts a regulatory effect on dendritic cells via a modulating effect of human homeobox gene VentX.
17-20. (canceled)
A method for suppressing a tumor, comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising a biological or chemical agent that exerts a modulating effect on dendritic cells function.
Dependencies are inferred from the claim text.